UK Markets close in 2 hrs 24 mins

Advicenne S.A. (ADVIC.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
7.05-0.07 (-0.98%)
As of 5:35PM CEST. Market open.
Full screen
Previous close7.12
Open7.14
BidN/A x N/A
AskN/A x N/A
Day's range7.05 - 7.24
52-week range5.32 - 16.25
Volume13,459
Avg. volume38,421
Market cap60.683M
Beta (5Y monthly)1.07
PE ratio (TTM)N/A
EPS (TTM)-1.75
Earnings date28 Apr 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA

    Advicenne Receives MHRA Approval to Market Sibnayal™ (ADV7103) in the UK for the Treatment of dRTA Paris, France, 2nd July 2021 – 7 am CEST – Advicenne (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, is pleased to announce that the Medicines & Healthcare products Regulatory Agency (MHRA) has today granted marketing authorisation for Sibnayal™ (ADV7103) in the UK, for the treatmen

  • Business Wire

    Advicenne Successfully Raises Circa € 9.4 Million in a Placement Reserved to a Category of Persons

    PARIS, June 23, 2021--Regulatory News: Advicenne SA (FR0013296746 - ADVIC) (the "Company"), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, today announced the successful capital increase of circa € 9.4 million by means of issuance of 1,319,507 new ordinary shares (the "New Shares") reserved to the category of investors described below (the "Offering").

  • Business Wire

    Advicenne Provides an Update on Its Activities Following Its Annual General Meeting

    PARIS, Jun 15, 2021--Regulatory News: Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext: ADVIC), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, provides an update on its activities following its Annual General Meeting, which was held virtually on June 14, 2021.